As an alternative to treatment approaches designed to block pro-inflammatory cytokine responses, we suggest that COVID-19-associated SARS may be better prevented or treated by instead increasing the activation and numbers of macrophages and microglia, in particular byincreasing the levels of GM-CSF. This evidence concerns the gene CSF2 and COVID-19.